Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy
about
Emerging surgical therapies in the treatment of pediatric epilepsyAquaporin-4 water channels and synaptic plasticity in the hippocampusIssues related to development of antiepileptogenic therapies.Anti-epileptogenic clinical trial designs in epilepsy: issues and optionshPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice.Epilepsy therapy development: technical and methodologic issues in studies with animal modelsSeizures and epilepsy: an overview for neuroscientistsChronic behavioral and cognitive deficits in a rat survival model of paraoxon toxicityInvestigating the potential of the anti-epileptic drug imepitoin as a treatment for co-morbid anxiety in dogs with idiopathic epilepsyThe influence of ectopic migration of granule cells into the hilus on dentate gyrus-CA3 function.Cause-specific mortality in adult epilepsy patients from Tyrol, Austria: hospital-based studyEarly life seizures: evidence for chronic deficits linked to autism and intellectual disability across species and models.Impaired cognitive ability and anxiety-like behavior following acute seizures in the Theiler's virus model of temporal lobe epilepsyIs plasticity of GABAergic mechanisms relevant to epileptogenesis?Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouseAntidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsyExpression of the Astrocyte Water Channel Aquaporin-4 in the Mouse BrainAutism Spectrum Disorder and Epilepsy: Two Sides of the Same Coin?Identification of a distinct developmental and behavioral profile in children with Dup15q syndromeReactive oxygen species mediate cognitive deficits in experimental temporal lobe epilepsy.The challenge and promise of anti-epileptic therapy development in animal models.Disease modification in epilepsy: from animal models to clinical applications.Glutamatergic Mechanisms Associated with Seizures and Epilepsy.Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy.Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model.Acute cognitive impact of antiseizure drugs in naive rodents and corneal-kindled mice.Acute treatment with minocycline, but not valproic acid, improves long-term behavioral outcomes in the Theiler's virus model of temporal lobe epilepsy.Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy.Specific alterations in the performance of learning and memory tasks in models of chemoconvulsant-induced status epilepticus.Neurology--the next 10 years.Behavioral and neuroendocrine assays for studying epilepsy-associated depression.Affective symptoms and determinants of health-related quality of life in Mexican people with epilepsy.Corneal kindled C57BL/6 mice exhibit saturated dentate gyrus long-term potentiation and associated memory deficits in the absence of overt neuron loss.Not all that glitters is gold: A guide to critical appraisal of animal drug trials in epilepsy.miRNA-Mediated Regulation of Adult Hippocampal Neurogenesis; Implications for Epilepsy.Changes in the Blood-Brain Barrier Function Are Associated With Hippocampal Neuron Death in a Kainic Acid Mouse Model of EpilepsyA companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force
P2860
Q26749102-DA56B2F7-44C2-4E17-8F59-5E3D1B3F5404Q27007481-090A1399-247A-423F-A495-FD67D078BAD0Q27016115-3CD97A83-3F41-496D-8900-539BDF9267F5Q27027689-ED44CD5F-81AF-4A38-B6A4-117AEFDE59E1Q27303692-83A490DA-06D7-4A3A-B4B3-9CC27F4E5ED8Q30543230-9421F1EF-AB83-46A4-BEA1-256BE595757FQ33165796-FC0CB3EB-483D-4C3A-90B7-0D67F14122CEQ34243561-D02CC5A4-F351-4B0A-ABDC-26E4719ACC4BQ34554961-87F6762D-F600-49A6-A61F-06C7DBEA6600Q34808645-67D03B17-E535-470D-97DB-A45B80ECC62BQ34907215-236E0730-979A-4AA4-91D5-829336CE0AA9Q35116253-6D115B10-632E-4E0A-8E04-756ED9811A8DQ35159209-D4D27107-BA49-4D70-84DF-F2660E934965Q35207594-59CC27C4-38ED-4A7B-944D-6521BB219645Q35531800-3CB00997-0ED9-4A52-9925-C108B74F5302Q35693028-9A7FFB63-F0A2-473D-BC41-8732D117381CQ36216481-A56842AB-91C1-43A6-B8C8-599DCD255B3DQ36289317-32D4F7BF-C776-4B95-AF7D-7484941EEC8DQ36876026-7EC24AC6-EBCF-4731-8E5C-BBE7FF36C3CCQ36912566-E533BBFA-B3C6-4480-9653-F659AA25E974Q37214420-D513E8B3-10A4-497D-AA92-D05A21353A5BQ38450069-F9781A1F-5E37-4F6A-BA65-E84D1FC03E8DQ38535033-EAEDE070-F2AE-4563-A99B-8B607FA234F6Q38694553-29A5861A-F9BA-4685-9C16-FF00C241A994Q38707729-BFB3DE28-365D-40DA-8D90-B642D55CBFF2Q39552330-3828E2EE-5BE3-40C3-8102-7B507D8D5CBEQ40507200-92AD4453-46ED-4CAD-A1C4-8DB8C0124511Q41484370-39BB2B9B-9204-484E-8629-A326F2D40610Q41879146-38BC5308-A411-4DDB-B411-E4C93D4B1002Q46374782-A1851049-4E73-4A40-8FBB-5EA7C2A0DF22Q46816463-0E095496-B12B-4A78-859A-82541A2C4C88Q47704807-EF1D162B-59A2-46DA-8C3A-CEC7C4AF083EQ50579165-D2005CC1-B74E-4A67-B455-02F5E5060B01Q51818804-38713EFE-711C-48CA-9FDE-AF18B7DAE288Q55254308-1D80F393-A30E-412A-B46F-7C3571203364Q58746449-02FA81BC-1294-4112-BBB3-0BFE3A094D1EQ59137534-53C116FA-44A8-4044-A578-7354B8688B6C
P2860
Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Issues related to symptomatic ...... tric comorbidities of epilepsy
@ast
Issues related to symptomatic ...... tric comorbidities of epilepsy
@en
Issues related to symptomatic ...... tric comorbidities of epilepsy
@nl
type
label
Issues related to symptomatic ...... tric comorbidities of epilepsy
@ast
Issues related to symptomatic ...... tric comorbidities of epilepsy
@en
Issues related to symptomatic ...... tric comorbidities of epilepsy
@nl
prefLabel
Issues related to symptomatic ...... tric comorbidities of epilepsy
@ast
Issues related to symptomatic ...... tric comorbidities of epilepsy
@en
Issues related to symptomatic ...... tric comorbidities of epilepsy
@nl
P2093
P2860
P3181
P356
P1433
P1476
Issues related to symptomatic ...... tric comorbidities of epilepsy
@en
P2093
Amy R Brooks-Kayal
Andres M Kanner
Anne T Berg
Aristea S Galanopoulou
Frances E Jensen
Gregory L Holmes
Helen E Scharfman
Kevin G Bath
Manisha Patel
Melodie R Winawer
P2860
P3181
P356
10.1111/EPI.12298
P407
P478
54 Suppl 4
P577
2013-08-01T00:00:00Z